Press release
Biopsy Devices Market Forecast 2019 with CareFusion, Hologic, Inc. , Mammotome, a Division of Devicor Medical Pro
The Biopsy Devices Market set to exceed is expected to witness growth of over 6.5% CAGR from 2018 to 2024 new research report by Global Market Insights.Rising prevalence of cancer and infections will stimulate biopsy devices market growth over the forthcoming period. Infectious diseases are rapidly emerging worldwide due to changing environmental conditions and rising population.
According to World Health Organization, 50,000 people worldwide die from infectious diseases. In addition, infections with new and unknown causative agents have increased tremendously during recent years. Biopsy is thus a crucial tool for histopathological examination of tissue. Rising number of kidney disorders, infections and rising cancer incidence should increase the market size over the upcoming period.
Growing awareness regarding breast cancer treatment and diagnosis will support increase in biopsy devices market size in upcoming years. Several countries hold campaigns and programs for early diagnosis of breast cancer. In U.S., early detection camps are set-up in rural areas wherein diagnosis of cancer is done through biopsy of suspicious lesions and oral examinations, every four months. Such initiatives will accelerate the adoption rate of biopsy devices, thereby positively impacting biopsy devices business growth in foreseeable future.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/731
Technological advancements in biopsy devices will lead to faster adoption of biopsy devices in coming years. Conventional biopsy for prostate biopsy without using imaging guidance technology render negative tests or misses tumor in maximum cases. Thus, evolution of technologies such as MRI/ultrasound for accurate and reliable diagnosis of lesions is leading to faster adoption of biopsy procedures. Koelis developed Organ-Based Tracking (OBT) Revolution that works in tandem with elastic fusion technology, thus maximizing accuracy of the procedure. Such innovations allowing better and improved diagnosis of abnormalities will drive global biopsy devices industry over the upcoming period.
Biopsy guidance systems segment accounted for largest revenue size of USD 855.4 million in 2017. As per data from Journal of Clinical Pathways, during the recent years, more than half biopsies were guided by computed tomography systems and other procedures such as ultrasound/fluoroscopy. Guidance systems offer high-definition images of the abnormalities/tissue, are minimally invasive as well as cost-effective. In addition, several companies are concentrating on R&D to innovate newer imaging technologies that should impel biopsy guidance systems segment growth over the forecast timeframe.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
CareFusion
Hologic, Inc. ,
Mammotome, a Division of Devicor Medical Pro
Needle based biopsy guns segment is forecasted to grow at 7.2% CAGR during the forecast period. Fine needle aspiration (FNA) is minimally invasive procedure and requires extraction of only fewer cells for diagnosis. Needle-based biopsy is reliable and offers accurate diagnosis of the abnormalities/disease. Above benefits of needle-based biopsy guns coupled with increasing demand for minimally invasive procedures will spur segmental growth.
Hospitals end-user segment held the largest market share of 69.2% in 2017 and will dominate the market throughout the forecast timeframe. Biopsy accounts for the most frequently performed procedures in hospital settings. As per Journal of Clinical Pathways, image-guided percutaneous liver biopsy (PLB) is rising at a fast pace in patients affected by hepatocellular carcinoma. With escalating epidemiology of infectious diseases along with rising healthcare spending, hospitals end-user segment is forecasted to grow robustly in coming years.
Browse Full Report Details @ https://www.gminsights.com/industry-analysis/biopsy-devices-market
Ambulatory surgical centers (ASCs) end-user segment will record high CAGR at 9.0% over the projected period. ASCs are witnessing rapid demand for procedures due to its speciality, faster procedural time as well as shorter stays. Availability of reimbursement for biopsy devices coupled with procedural reimbursement will further serve as high impacting factor, favouring significant segmental growth in future.
U.S. market accounted for highest revenue share of 81.0% North America biopsy devices market in 2017. Expanding cases of cancer coupled with growing awareness of cancer diagnosis and treatment in the country is estimated to offer accelerating demand for biopsy devices in future. For instance, October is considered as the breast cancer awareness month, wherein rallies, breast-cancer awareness campaigns and events are held. Furthermore, sophisticated healthcare infrastructure and growing prevalence of infections will positively impact U.S. biopsy devices industry growth over the projected timeframe.
France market will grow at remarkable pace of 6.2% throughout the forecast period. Growing incidence of cancer will act as a high impacting factor for France market growth. According to Cancer Organisation Soutien, 385,000 new cases of cancer were diagnosed in France in the year 2015 and incidence of cancer is increasing considerably. In addition, breast cancer is the leading cause of mortality in women. With such accelerating pervasiveness of cancer, France biopsy devices will foresee lucrative growth over forthcoming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/731
Biopsy was formerly performed in Russia by M. M. Rudnev in 1875 followed by first breast biopsy performed during 1850s by Skey, Sr. James Paget, John Eric Erichsen and Prtichard. The evolution of first biopsy needle can be dated back to early 1930s. During 1981, analog mammography system Mammomat B by Siemens Healthineers offered biopsy paddle for localization of needle under mammography supervision.
Subsequent developments in other biopsy types such as prostate biopsy, renal biopsy and infections through technological advancements including imaging-guided biopsy marked robust industrial growth. Additionally, renal biopsy will foresee lucrative growth opportunity as a result of rapid developments in imaging technologies including Magnetic particle imaging (MPI) modality that allows localization of localization of super paramagnetic nanoparticles at high resolution. Such advancements are forecasted to spur biopsy devices industrial growth in foreseeable future.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopsy Devices Market Forecast 2019 with CareFusion, Hologic, Inc. , Mammotome, a Division of Devicor Medical Pro here
News-ID: 1531263 • Views: …
More Releases from Global Market Insights, Inc

Point of Care Ultrasound Market Outlook 2021-2025 | Analogic, Canon Medical Syst …
Growing demand for fast and accurate diagnostic tools is expected to drive point of care ultrasound market growth in the ensuing years. Point-of-care ultrasound (POCUS) has become a standard tool in the emergency department, as it answers to specific clinical queries that narrow differentials, guide clinical therapy, and direct consultations and disposition.
Recent technological advancements have led to the development of miniature POCUS that range from stationary high-end systems to small…

Medical Tourism Market Forecast 2027 By Top Players Asklepios, KPJ Healthcare Bh …
Medical Tourism Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Every year millions of people travel abroad seeking medical treatment and efficient surgical procedures such as cosmetic surgery, cardiovascular surgery, orthopedic and dental surgery which is referred to…

Medical X-ray Market Outlook 2021-2027 | Top Players Siemens Healthcare, GE Heal …
Medical X-ray Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Researchers at Northwestern University have designed a new AI-based platform that analyses lung X-rays and detects COVID-19. The machine-learning (ML) algorithm, named DeepCOVID-XR, was able to outperform a…

Biosensors Market 2021 by Top Industry Players Abbott Laboratories, Bio-Rad Inte …
Biosensors Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Rising incidences of several serious disorders among the global population has evoked the need to detect these at early stages in order to obtain appropriate treatment on time. This…
More Releases for Biopsy
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023.
Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.
KEY PLAYERS OF NEEDLE…
Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biops …
Researchmoz added Most up-to-date research on "Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biopsy Tables, Guidance Systems & Localization Wires" to its huge collection of research reports.
The global Breast Biopsy Devices market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.
Japan plays an…